Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 1/2 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Classical hematology 2

Conditions

Leukemia 60Myelodysplastic Syndromes 53Leukemia, Myeloid, Acute 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Leukemia, Lymphocytic, Chronic, B-Cell 42Lymphoma, Non-Hodgkin 41Hodgkin Disease 38Multiple Myeloma 35Lymphoma, Mantle-Cell 33Lymphoma 33Lymphoma, Large B-Cell, Diffuse 31Lymphoma, Follicular 30Leukemia, Myeloid, Chronic-Phase 30Myeloproliferative Disorders 27Lymphoma, B-Cell, Marginal Zone 27Burkitt Lymphoma 26Congenital Abnormalities 25Lymphoma, Large-Cell, Immunoblastic 24Anemia, Refractory, with Excess of Blasts 24Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Leukemia, Myeloid, Accelerated Phase 21Graft vs Host Disease 21Leukemia, Myelomonocytic, Chronic 20Blast Crisis 19Dendritic Cell Sarcoma, Interdigitating 17Anemia, Refractory 17Recurrence 16Waldenstrom Macroglobulinemia 15Neoplasms, Plasma Cell 15Myelodysplastic-Myeloproliferative Diseases 15

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Cyclosporine × Clear all
NCT00001880 2021-11-10

Stem Cell Transplantation for Metastatic Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
42 enrolled 11 charts

Graft vs Host Disease, Neoplasm Metastasis, Neoplasms

NCT00185692 2019-12-04

Allogeneic Transplantation From Related Haploidentical Donors

Stanford University

Phase 2 Completed
16 enrolled 8 charts
LymphoidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Leukemia, Neoplasms, Hematologic Neoplasms

NCT00895739 2013-08-12

Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

National Cancer Institute (NCI)

Phase 2 Unknown
50 enrolled
Classical hematology

Anemia, Aplastic, Neoplasms

NCT00795132 2013-07-30

Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies

University of Utah

Phase 2 Completed
47 enrolled 8 charts
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Chronic Disease, Leukemia, Lymphoma, Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡